These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

416 related items for PubMed ID: 29707074

  • 1. Hepatobiliary Manifestations and Complications in Inflammatory Bowel Disease: A Review.
    Fousekis FS, Theopistos VI, Katsanos KH, Tsianos EV, Christodoulou DK.
    Gastroenterology Res; 2018 Apr; 11(2):83-94. PubMed ID: 29707074
    [Abstract] [Full Text] [Related]

  • 2. Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver.
    Rojas-Feria M, Castro M, Suárez E, Ampuero J, Romero-Gómez M.
    World J Gastroenterol; 2013 Nov 14; 19(42):7327-40. PubMed ID: 24259964
    [Abstract] [Full Text] [Related]

  • 3. Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disorders.
    Mazza S, Soro S, Verga MC, Elvo B, Ferretti F, Cereatti F, Drago A, Grassia R.
    World J Hepatol; 2021 Dec 27; 13(12):1828-1849. PubMed ID: 35069993
    [Abstract] [Full Text] [Related]

  • 4. Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease.
    Navaneethan U, Shen B.
    Inflamm Bowel Dis; 2010 Sep 27; 16(9):1598-619. PubMed ID: 20198712
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Hepatic manifestations of inflammatory bowel diseases.
    Restellini S, Chazouillères O, Frossard JL.
    Liver Int; 2017 Apr 27; 37(4):475-489. PubMed ID: 27712010
    [Abstract] [Full Text] [Related]

  • 7. Hepatobiliary manifestations of inflammatory bowel disease.
    Yarur AJ, Czul F, Levy C.
    Inflamm Bowel Dis; 2014 Sep 27; 20(9):1655-67. PubMed ID: 24874461
    [Abstract] [Full Text] [Related]

  • 8. [Hepatobiliary Manifestation of Inflammatory Bowel Disease].
    Seo KI, Kang SB.
    Korean J Gastroenterol; 2019 May 25; 73(5):248-259. PubMed ID: 31132831
    [Abstract] [Full Text] [Related]

  • 9. Hepatobiliary and pancreatic manifestations in inflammatory bowel diseases: a referral center study.
    Fousekis FS, Katsanos KH, Theopistos VI, Baltayiannis G, Kosmidou M, Glantzounis G, Christou L, Tsianos EV, Christodoulou DK.
    BMC Gastroenterol; 2019 Apr 03; 19(1):48. PubMed ID: 30943899
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Systematic review: The epidemiology of the hepatobiliary manifestations in patients with inflammatory bowel disease.
    Gizard E, Ford AC, Bronowicki JP, Peyrin-Biroulet L.
    Aliment Pharmacol Ther; 2014 Jul 03; 40(1):3-15. PubMed ID: 24815622
    [Abstract] [Full Text] [Related]

  • 14. Current approach to hepatobiliary manifestations in inflammatory bowel disease.
    Majchrzak K, Dudek P, Talar-Wojnarowska R, Fichna J.
    J Physiol Pharmacol; 2021 Oct 03; 72(5):. PubMed ID: 35158328
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. What is the association of primary sclerosing cholangitis with sex and inflammatory bowel disease in Turkish patients?
    Bayraktar Y, Arslan S, Saglam F, Uzunalimoglu B, Kayhan B.
    Hepatogastroenterology; 1998 Oct 03; 45(24):2064-72. PubMed ID: 9951867
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Hepatobiliary complications of idiopathic intestinal inflammations].
    Lukás M.
    Cas Lek Cesk; 1997 Feb 12; 136(4):106-10. PubMed ID: 9221179
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.